DiaSys Diagnostic Systems, USA, expands in U.S. Veterinary market

In an effort to help Veterinarians and reference laboratories deliver highly accurate and cost effective diagnostic blood testing, DiaSys Diagnostic Systems, USA, LLC has entered an exclusive distribution partnership with Zoetis Services LLC.

This exclusive agreement covers the sales and marketing of our veterinary chemistry products and services to veterinary clinics, veterinary reference laboratories, animal shelters, university reference laboratories and livestock laboratories on farms. This partnership will provide DiaSys greater access to the broader veterinary market in the U.S. by leveraging Zoetis’ large footprint of sales and support personnel already deployed to these important segments. A broad team of DiaSys personnel have worked tirelessly to prepare for the commercial launch by private labeling the respons®910VET system as the new Zoetis CARYSTA™ HVC system. “We selected Zoetis because they have a history of delivering high quality, innovative therapeutics and have demonstrated a desire to deliver greater efficiency and productivity in diagnostic solutions. Zoetis will be able to demonstrate the intrinsic value offered by flexible test selection and higher volume test performance of the CARYSTA™ HVC” says Douglas Danne, CEO, DiaSys USA. The system was introduced to the U.S. market at this year’s VMX and WVC veterinary conferences. The first production run of CARYSTA™ HVC are being delivered to Zoetis for use in sales demonstrations with commercial placements anticipated to begin in June.